课题基金 / 基金详情

Overcoming cisplatin resistance through p53 gene using caffeine in osteosarcoma

Overcoming cisplatin resistance through p53 gene using caffeine in osteosarcoma
在骨肉瘤中使用咖啡因通过 p53 基因克服顺铂耐药性
批准号:
11671426
负责人:
TSUCHIYA Hiroyuki
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

TSUCHIYA Hiroyuki的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1) Alteration of p53 gene in human osteosarcoma cell lines : There was no overexpression of p53 gene and no point mutation from exon 5 to exon 8 in both OST cell line (sensitive to cisplatin) and OST-R cell line (resistant to cisplatin). It was considered that these two cell lines expressed wild-type p53 protein.2) Analysis of p53 deletion in cisplatin-resistant human osteosarcoma cell (OST-R) : Deletion of p53 gene was significantly increased in OST-R cells. As the amount of p53 protein was decreased corresponding with this deletion, the function of p53 was suppressed and the instability of chromosome 17 was increased in OST-R.Perhaps, the function loss of p53 gene and protein would be an indicator of acquired cisplatin resistance in human osteosarcoma.3) Alteration of p53 gene expression after chemotherapy and growth inhibition by controlling p53 expression : Caffeine has DNA-repair inhibiting effect and suppress p53 overexpression. The cytocidal effect of cisplatin was increased by caffeine in OST cells, but not in OST-R.The expression of p53 protein was overexpressed after cisplatin treatment and caffeine suppressed this overexpression in OST cells. Caffeine could not overcome the acquired cisplatin-resistance in human osteosarcoma.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Tsuchiya H, Mori Y, Ueda Y, Okada G, Tomita K: "Sensitization and Caffeine Potentiation of Cisplatin Cytotoxicity Resulting from Introduction of Wild-Type p53 Gene in Human Osteosarcoma."Anticancer Res. 20. 235-242 (2000)
Tsuchiya H、Mori Y、Ueda Y、Okada G、Tomita K:“在人类骨肉瘤中引入野生型 p53 基因导致顺铂细胞毒性的敏化和咖啡因增强。”抗癌研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
毛利良彦: "野生型p53遺伝子導入とカフェイン併用によるヒト骨肉腫細胞の抗癌剤感受性の増強"金沢大学十全医学会雑誌. 107. 493-503 (1998)
Yoshihiko Mori:“通过野生型p53基因导入和咖啡因的联合使用增强人骨肉瘤细胞的抗癌药物敏感性”金泽大学十善医学会杂志107. 493-503(1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Asada N, et al: "De Novo Deletions of p53 Gene and Wild-Type p53 Correlate with Acquired Cisplatin-Resistance in Human Osteosarcoma OST Cell Line."Anticancer Res. 19. 5131-5138 (1999)
Asada N 等人:“p53 基因和野生型 p53 的从头删除与人骨肉瘤 OST 细胞系中获得性顺铂耐药性相关。”Anticancer Res。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Regulation of liver cancer stem cells by a lncRNA
  • 批准号:
    19K08469
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.83万
  • 财政年份:
    2019
  • 负责人:
    TSUCHIYA Hiroyuki
  • 依托单位:
cryoimmunotherapy for malignant bone tumors
  • 批准号:
    24650631
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.41万
  • 财政年份:
    2012
  • 负责人:
    TSUCHIYA Hiroyuki
  • 依托单位:
Treatment strategy and analysis of progression mechanism of musculoskeletal tumors using fluorescent imaging
  • 批准号:
    23390360
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $10.07万
  • 财政年份:
    2011
  • 负责人:
    TSUCHIYA Hiroyuki
  • 依托单位:
Investigation of the mechanisms of hepatic insul in sensitization by retinoi cacid.
  • 批准号:
    23790819
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.66万
  • 财政年份:
    2011
  • 负责人:
    TSUCHIYA Hiroyuki
  • 依托单位: